Wall Street brokerages expect Aramark (NYSE:ARMK) to report sales of $3.90 billion for the current quarter, according to Zacks. Twelve analysts have issued estimates for Aramark’s earnings, with the highest sales estimate coming in at $4.00 billion and the lowest estimate coming in at $3.78 billion. Aramark reported sales of $3.62 billion in the same quarter last year, which would suggest a positive year-over-year growth rate of 7.7%. The business is scheduled to report its next quarterly earnings results on Tuesday, May 8th.
On average, analysts expect that Aramark will report full year sales of $3.90 billion for the current financial year, with estimates ranging from $15.18 billion to $16.01 billion. For the next fiscal year, analysts forecast that the company will post sales of $16.37 billion per share, with estimates ranging from $15.68 billion to $16.90 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research analysts that cover Aramark.
Aramark (NYSE:ARMK) last issued its earnings results on Tuesday, February 6th. The company reported $0.54 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.51 by $0.03. Aramark had a return on equity of 18.68% and a net margin of 3.65%. The business had revenue of $3.97 billion during the quarter, compared to analysts’ expectations of $3.88 billion. During the same quarter in the prior year, the firm earned $0.55 EPS. The business’s revenue for the quarter was up 6.2% compared to the same quarter last year.
ARMK has been the topic of a number of analyst reports. Stifel Nicolaus initiated coverage on Aramark in a research report on Tuesday, December 19th. They issued a “buy” rating and a $50.00 price target on the stock. Barclays upped their price target on Aramark from $45.00 to $47.00 and gave the company an “equal weight” rating in a research report on Friday, December 22nd. Zacks Investment Research upgraded Aramark from a “sell” rating to a “hold” rating in a research report on Wednesday, November 22nd. Nomura reduced their price target on Aramark from $47.00 to $45.00 and set a “buy” rating on the stock in a research report on Wednesday, November 15th. Finally, Credit Suisse Group reiterated an “outperform” rating and issued a $50.00 price target on shares of Aramark in a research report on Wednesday, January 24th. Three equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $47.00.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in ARMK. BlackRock Inc. boosted its position in shares of Aramark by 2.3% during the 4th quarter. BlackRock Inc. now owns 13,588,423 shares of the company’s stock valued at $580,771,000 after purchasing an additional 302,749 shares in the last quarter. Atlanta Capital Management Co. L L C boosted its position in shares of Aramark by 2.4% during the 4th quarter. Atlanta Capital Management Co. L L C now owns 10,219,239 shares of the company’s stock valued at $436,770,000 after purchasing an additional 238,109 shares in the last quarter. First Manhattan Co. boosted its position in shares of Aramark by 7.4% during the 4th quarter. First Manhattan Co. now owns 5,187,057 shares of the company’s stock valued at $221,694,000 after purchasing an additional 355,984 shares in the last quarter. TIAA CREF Investment Management LLC boosted its position in shares of Aramark by 6.5% during the 4th quarter. TIAA CREF Investment Management LLC now owns 3,516,803 shares of the company’s stock valued at $150,308,000 after purchasing an additional 214,992 shares in the last quarter. Finally, Frontier Capital Management Co. LLC boosted its position in shares of Aramark by 0.3% during the 3rd quarter. Frontier Capital Management Co. LLC now owns 3,466,544 shares of the company’s stock valued at $140,776,000 after purchasing an additional 10,207 shares in the last quarter. Hedge funds and other institutional investors own 91.70% of the company’s stock.
Shares of Aramark (NYSE:ARMK) traded down $0.15 on Monday, reaching $41.37. The company’s stock had a trading volume of 502,996 shares, compared to its average volume of 1,400,029. Aramark has a fifty-two week low of $35.56 and a fifty-two week high of $46.09. The company has a current ratio of 1.40, a quick ratio of 1.09 and a debt-to-equity ratio of 2.56. The firm has a market cap of $10,182.34, a PE ratio of 19.34, a PEG ratio of 1.74 and a beta of 0.51.
The business also recently declared a quarterly dividend, which will be paid on Thursday, March 1st. Shareholders of record on Wednesday, February 14th will be given a $0.105 dividend. The ex-dividend date is Tuesday, February 13th. This represents a $0.42 dividend on an annualized basis and a dividend yield of 1.02%. Aramark’s dividend payout ratio (DPR) is presently 19.53%.
WARNING: “Zacks: Analysts Anticipate Aramark (ARMK) Will Announce Quarterly Sales of $3.90 Billion” was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this report on another domain, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this report can be read at https://www.dispatchtribunal.com/2018/02/22/zacks-analysts-anticipate-aramark-armk-will-announce-quarterly-sales-of-3-90-billion.html.
Aramark is a global provider of food, facilities and uniform services to education, healthcare, business and industry, and sports, leisure and corrections clients. The Company operates through three segments: Food and Support Services North America (FSS North America), Food and Support Services International (FSS International), and Uniform and Career Apparel (Uniform).
Get a free copy of the Zacks research report on Aramark (ARMK)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Aramark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aramark and related companies with MarketBeat.com's FREE daily email newsletter.